What Should Everyone Know on National Herpes Awareness Day?

TL;DR

National Herpes Awareness Day, observed each year on October 13, highlights that herpes is common, often silent and manageable, but not curable. The WHO estimates 3.8 billion people under 50 have HSV-1 and 520 million aged 15 to 49 have HSV-2. Monolaurin has laboratory data against enveloped viruses but no clinical trial for herpes.

Key Takeaways

• National Herpes Awareness Day falls on October 13, which is a Tuesday in 2026, and its purpose is to replace stigma with accurate information about herpes simplex virus (HSV).
• Herpes is among the most common viral infections in the world, and the CDC notes that most people with genital herpes do not know they have it.
• HSV can spread through asymptomatic shedding, and suppressive antiviral therapy, condoms, selective abstinence and disclosure to partners have each been shown to reduce transmission risk.
• A 2022 systematic review found that a diagnosis often carries a significant emotional impact, including stigma and disclosure stress.
• Monolaurin may support immune balance as an educational topic, but no human trial has tested it for herpes, and it is not a substitute for medical care or antiviral medication.

What Is National Herpes Awareness Day?

National Herpes Awareness Day is observed each year on October 13, a Tuesday in 2026. The day centers on three ideas: herpes is far more common than most people assume, the stigma around it is out of proportion to its medical impact, and accurate information protects both people living with HSV and the people around them.

This is also a good moment to separate what the research shows from what it does not. That includes research on monolaurin, a compound made from the lauric acid in coconut oil, which comes up often in conversations about herpes.

How Common Is Herpes?

Very common. The WHO estimates that 3.8 billion people under 50, or 64%, have HSV-1, which usually causes oral cold sores. It also estimates that 520 million people aged 15 to 49, or 13%, had HSV-2, the type most often linked to genital herpes, in 2020.

In the United States, the CDC estimated 572,000 new genital herpes infections in 2018 among people aged 14 to 49. It also states that most people with a herpes infection do not know they have it, because symptoms can be absent or mild enough to go unnoticed. HSV-1 is no longer only an oral virus: a 2026 review in Diagnostics notes that HSV-1 has emerged as a significant cause of genital herpes as well.

Why Does Stigma Matter So Much?

Herpes is common, yet the emotional weight can be heavy. The WHO notes that genital herpes may be stigmatizing and affect sexual relationships.

A 2022 mixed-methods systematic review in JBI Evidence Synthesis pooled 31 publications on genital herpes and quality of life. Depression, anxiety, stress, isolation, stigma and lowered self-esteem may be experienced by both newly diagnosed people and those with recurrences. Disclosure to partners emerged as a dilemma and a source of stress. The review also found that psychosocial interventions, hypnosis and antiviral treatment improved mood, anxiety or quality of life, which suggests that support can help.

What Do the Facts Say About Spread and Protection?

The CDC states that even without symptoms, a person with genital herpes can still infect partners, because the virus can shed from skin without visible sores. Awareness gaps are real: in a 2024 survey of 304 adults in Saudi Arabia reported in the Journal of Infection in Developing Countries, fewer than half knew that HSV-2 can recur many times or spread from people without symptoms.

A 2025 dermatology review in Clinics in Dermatology describes four approaches shown to reduce transmission risk: suppressive antiviral therapy, condoms, selective abstinence and disclosure to sexual partners. The WHO adds that condoms reduce risk but do not remove it, since HSV can pass through contact with areas the condom does not cover. For those reasons, protection works best as a combination, not a single measure.

Is There a Cure, and What Does Medical Care Offer?

There is no cure. The WHO says antiviral medicines can shorten and soften symptoms but cannot cure the infection, and the CDC says daily suppressive therapy can lower the chance of passing the virus to a partner. A 2023 review in Infectious Disease Clinics of North America adds that these medicines can reduce recurrences, shedding and transmission.

Pregnancy deserves a conversation with a clinician. The 2026 Diagnostics review reports that acyclovir and valacyclovir are considered safe in pregnancy and that suppressive therapy from 36 weeks reduces recurrences and shedding at delivery. Testing questions, including which blood or swab test fits your situation, also belong with a healthcare provider.

How Does Immune Balance Fit In?

Many people living with HSV notice that outbreaks follow stress, illness, sun exposure or hormonal shifts, all of which the WHO lists among recognized triggers. Learning your own pattern is a practical form of self-knowledge. The site’s guides on tracking triggers and immune balance and on transmitting herpes without visible symptoms go deeper on both topics.

Where Does Monolaurin Fit in the Conversation?

Monolaurin’s link to herpes is structural. HSV is wrapped in a lipid envelope, and a classic laboratory study by Hierholzer and Kabara (1982) found that monolaurin reduced the infectivity of 14 human enveloped viruses by more than 99.9% in cell culture. Research suggests this mechanism may support immune balance as an educational topic.

The limits matter just as much:

• No clinical trial. No clinical trial of monolaurin for herpes is indexed in PubMed.
• Lab results do not equal human results. Cell culture does not reproduce what happens in the body.
• Formulation matters. A 2010 mouse study found that a 5% glycerol monolaurate preparation applied vaginally increased susceptibility to HSV-2. That was a topical genital model, not an oral supplement, but it shows why results cannot be assumed to carry over.

Monolaurin is a dietary supplement. It is not a treatment, not a cure and not a replacement for prescribed antivirals. The site’s article on what the research says and what people report covers the evidence in more detail.

How Can You Take Part in National Herpes Awareness Day?

Small actions count more than grand ones:

1. Learn the basics from reliable sources such as the WHO and CDC pages cited here.
2. Use plain, non-judgmental language. Words like “clean” and “dirty” feed the stigma the day is trying to reduce.
3. Talk to a healthcare provider about testing, suppressive therapy and any pregnancy plans.
4. Share facts, not fear. Herpes is common, usually manageable and not a measure of a person’s character.
5. Check in on someone who may have just been diagnosed. The 2022 review found that a new diagnosis often has a significant emotional impact.

What Should You Look For in a Monolaurin Supplement?

For readers who still want to explore monolaurin as a general immune support topic, a neutral checklist helps:

• Ingredient form: monolaurin (glycerol monolaurate) is different from lauric acid or coconut oil, and the label should say which is inside.
• Amount per serving: the milligrams of monolaurin should be stated plainly, not buried in a proprietary blend.
• Third-party testing: a certificate of analysis for purity and contaminants signals manufacturing accountability.
• Simple formulation: a short ingredient list without unnecessary fillers.

Readers who want to compare options can start at shopmonolaurin.com.

Frequently Asked Questions

When is National Herpes Awareness Day?

It is observed every year on October 13, which falls on a Tuesday in 2026. The day aims to reduce stigma and encourage honest, informed conversations about herpes.

Is herpes curable?

No. The WHO and CDC both state there is no cure for herpes. Antiviral medicines can shorten outbreaks, reduce recurrences and lower transmission risk, but the virus stays in the body.

Can herpes spread when there are no symptoms?

Yes. The CDC states that people can pass HSV to partners even without visible sores, because the virus can shed from skin without symptoms. Suppressive therapy, condoms, selective abstinence and disclosure each reduce the risk.

What is the difference between HSV-1 and HSV-2?

HSV-1 usually causes oral cold sores, and HSV-2 is most often linked to genital herpes. A 2026 review notes that HSV-1 is also a significant cause of genital herpes, so the site of infection does not always match the type.

Can monolaurin cure herpes?

No. No clinical trial has tested monolaurin for herpes, and no supplement cures the infection. Laboratory studies show monolaurin disrupts the lipid envelope of some viruses, which does not establish an effect in people.

Summary

National Herpes Awareness Day is about accuracy and kindness. Herpes is among the most common infections in the world, it often goes unnoticed, and the emotional weight of a diagnosis can be significant. Medical care offers real tools, including suppressive therapy, condoms and honest disclosure, though none of them is a cure.

Monolaurin has a plausible mechanism and promising laboratory results but no human trial for herpes, so it fits only as an optional, educational add-on to discuss with a healthcare provider.

Continue Exploring

• Can You Transmit Herpes Without Visible Symptoms?
• Monolaurin for Herpes: What Does the Research Say and What Do People Report?
• How to Manage the Frequency of Herpes Outbreaks: Tracking Triggers and Immune Balance

References

1. World Health Organization. Herpes simplex virus fact sheet. who.int
2. Centers for Disease Control and Prevention. About Genital Herpes. cdc.gov
3. Silva Pereira S, et al. Maternal-fetal implications of herpes virus infection: an updated review. Diagnostics, 2026. DOI (PMID 42072773)
4. Bennett C, Rebafka A, Carrier J, Cook S, Edwards D. Impact of primary and recurrent genital herpes on the quality of life of young people and adults: a mixed methods systematic review. JBI Evidence Synthesis, 2022. DOI (PMID 35199654)
5. Ghazy AA, et al. Knowledge and attitude towards herpes simplex virus-2 in Al-Jouf region, Saudi Arabia. Journal of Infection in Developing Countries, 2024. DOI (PMID 39832254)
6. Clarke E. Herpes simplex virus (update on dermatologic aspects of sexually transmitted disease and human immunodeficiency virus). Clinics in Dermatology, 2025. DOI (PMID 41005542)
7. Van Wagoner N, Qushair F, Johnston C. Genital herpes infection: progress and problems. Infectious Disease Clinics of North America, 2023. DOI (PMID 37105647)
8. Hierholzer JC, Kabara JJ. In vitro effects of monolaurin compounds on enveloped RNA and DNA viruses. Journal of Food Safety, 1982. DOI (PMID 32336838)
9. Moench TR, Mumper RJ, Hoen TE, Sun M, Cone RA. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse. BMC Infectious Diseases, 2010. DOI (PMID 21087496)